164 related articles for article (PubMed ID: 36864281)
1. Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy.
Zhou J; Sun S; Zhang D; Mao J; Xiao H; Yao Y; Wang F; Yu L; Liu L; Feng C; Li C; Su B; Zhang H; Liu X; Xu K; Ju W; Zhong X; Ding J
Pediatr Res; 2023 Aug; 94(2):747-755. PubMed ID: 36864281
[TBL] [Abstract][Full Text] [Related]
2. Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome.
Gipson DS; Trachtman H; Waldo A; Gibson KL; Eddy S; Dell KM; Srivastava T; Lemley KV; Greenbaum LA; Hingorani S; Meyers KE; Kaskel FJ; Reidy KJ; Sethna CB; Tran CL; Wang CS; Tuttle KR; Oh G; Neu AM; Brown E; Lin JJ; Yee JL; Roth TM; Troost JP; Gillespie BW; Sampson MG; Kretzler M; Ju W
Kidney Int Rep; 2020 Apr; 5(4):414-425. PubMed ID: 32280839
[TBL] [Abstract][Full Text] [Related]
3. Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.
Li B; Zhang Y; Wang F; Nair V; Ding F; Xiao H; Yao Y; Kretzler M; Ju W; Ding J
Pediatr Nephrol; 2018 Oct; 33(10):1731-1739. PubMed ID: 29948307
[TBL] [Abstract][Full Text] [Related]
4. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
[TBL] [Abstract][Full Text] [Related]
5. Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis.
Wu L; Li XQ; Goyal T; Eddy S; Kretzler M; Ju WJ; Chen M; Zhao MH
Ann Rheum Dis; 2018 Sep; 77(9):1339-1344. PubMed ID: 29724728
[TBL] [Abstract][Full Text] [Related]
6. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
Chanrat E; Worawichawong S; Radinahamed P; Sathirapongsasuti N; Nongnuch A; Assanatham M; Udomsubpayakul U; Kitiyakara C
Cytokine; 2018 Apr; 104():1-7. PubMed ID: 29414320
[TBL] [Abstract][Full Text] [Related]
7. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
Azukaitis K; Ju W; Kirchner M; Nair V; Smith M; Fang Z; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Yalcinkaya F; Paripovic D; Harambat J; Cakar N; Alpay H; Lugani F; Mencarelli F; Civilibal M; Erdogan H; Gellermann J; Vidal E; Tabel Y; Gimpel C; Ertan P; Yavascan O; Melk A; Querfeld U; Wühl E; Kretzler M; Schaefer F; ;
Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
[TBL] [Abstract][Full Text] [Related]
8. Urinary Epidermal Growth Factor/Creatinine Ratio and Graft Failure in Renal Transplant Recipients: A Prospective Cohort Study.
Yepes-Calderón M; Sotomayor CG; Kretzler M; Gans ROB; Berger SP; Navis GJ; Ju W; Bakker SJL
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31614925
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis.
Idasiak-Piechocka I; Miedziaszczyk M; Woźniak A; Pawliczak E; Kaczmarek E; Oko A
Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1267-C1275. PubMed ID: 37721004
[TBL] [Abstract][Full Text] [Related]
10. Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation.
Chan J; Svensson M; Tannæs TM; Waldum-Grevbo B; Jenssen T; Eide IA
Am J Nephrol; 2022; 53(2-3):108-117. PubMed ID: 35104815
[TBL] [Abstract][Full Text] [Related]
11. The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Menez S; Wen Y; Xu L; Moledina DG; Thiessen-Philbrook H; Hu D; Obeid W; Bhatraju PK; Ikizler TA; Siew ED; Chinchilli VM; Garg AX; Go AS; Liu KD; Kaufman JS; Kimmel PL; Himmelfarb J; Coca SG; Cantley LG; Parikh CR
Kidney Int; 2023 Dec; 104(6):1194-1205. PubMed ID: 37652206
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.
Li Z; Zhao Z; Liu X; Su Z; Shang X; Wen J
Pediatr Nephrol; 2012 Dec; 27(12):2251-9. PubMed ID: 22773267
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
14. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
15. Urinary cMet as a prognostic marker in immunoglobulin A nephropathy.
An JN; Li L; Lee J; Yu SS; Kim JH; Lee J; Kim YC; Kim DK; Oh YK; Lim CS; Kim YS; Kim S; Yang SH; Lee JP
J Cell Mol Med; 2020 Oct; 24(19):11158-11169. PubMed ID: 32822114
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Urinary Epidermal Growth Factor to Creatinine Ratio to Predict 24-Hour Urine Epidermal Growth Factor and Interstitial Kidney Fibrosis in Patients with IgA Nephropathy.
Segarra A; Carnicer C; Jatem E; Martin M; Molina M; Perich C; Martinez C
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232037
[TBL] [Abstract][Full Text] [Related]
17. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
18. The Association of Glomerular Glucocorticoid Receptor Expression with Responsiveness to Corticosteroid Treatment in IgA Nephropathy.
Kee YK; Nam BY; Jhee JH; Park JT; Lim BJ; Yoo TH; Kang SW; Jeong HJ; Han SH
Am J Nephrol; 2019; 50(3):187-195. PubMed ID: 31408863
[TBL] [Abstract][Full Text] [Related]
19. Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.
Tatematsu M; Yasuda Y; Morita Y; Sakamoto I; Kurata K; Naruse T; Yamamoto R; Tsuboi N; Sato W; Imai E; Matsuo S; Maruyama S
Clin Exp Nephrol; 2012 Dec; 16(6):883-91. PubMed ID: 22618296
[TBL] [Abstract][Full Text] [Related]
20. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
Inker LA; Heerspink HJL; Tighiouart H; Chaudhari J; Miao S; Diva U; Mercer A; Appel GB; Donadio JV; Floege J; Li PKT; Maes BD; Locatelli F; Praga M; Schena FP; Levey AS; Greene T
Am J Kidney Dis; 2021 Sep; 78(3):340-349.e1. PubMed ID: 33775708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
